Navigation Links
China Medical Technologies Announces Receipt of SFDA Quality Testing Certificate for its SPR-based Analysis System
Date:3/25/2009

BEIJING, March 25 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company received quality testing certificate (the ''Certificate'') for its SPR-based Analysis System (the ''SPR System'') from one of the State Food and Drug Administration (the ''SFDA'') Quality Supervision and Testing Centres yesterday. To receive the Certificate, the Company's SPR System has passed all the safety and performance parameters required by the SFDA.

''The receipt of the Certificate marks an important milestone during the SFDA approval process for our SPR System,'' said Mr. Xiaodong Wu, Chairman and Chief Executive Officer of the Company. ''We will continue to work on the approval process which includes the commencement of 120 clinical trial samples by three SFDA authorized Tier-1 hospitals and subsequent administrative procedures by the SFDA before its approval. Meanwhile, we have commenced the clinical trial for our HPV-DNA Biosensor Chip. Another three SFDA authorized Tier-1 hospitals have collected over 1,000 clinical samples required by the SFDA to conduct the testing for our HPV Chip. They have processed about one- third of the samples and will continue to finish the remaining samples to submit the results for our SFDA approval process for our HPV Chip. We expect to receive the respective SFDA approval for our SPR System and HPV Chip before the end of 2009, which is in-line with our previous expectations. We will make announcement for each important milestone upon achievement during the SFDA approval process for both our SPR System and HPV Chip.''

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com .

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute ''forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as ''will,'' ''expects,'' ''anticipates,'' ''future,'' ''intends,'' ''plans,'' ''believes,'' ''estimates'' and similar statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

    For more information, please contact

     Winnie Yam
     Tel:   +86-10-6530-8833
     Email: IR@chinameditech.com

'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Information Security Technology, Inc. Announces that Its Medical Case Statistics Software Selected for Exclusive Contract
2. China Pharma Holdings, Inc. Reports Record 2008 Year End Financial Results and Corporate Updates
3. China Medicine Announces Conference Call to Discuss Fourth and Fiscal Year 2008 Results
4. China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores
5. China Nepstar Chain Drugstore Announces Dividend
6. China Sky One Medical to Attend Two Conferences in March
7. China Sky One Medical, Inc. Obtains SFDA Approval for Policresulen Vaginal Suppositories
8. China Pharma Holdings, Inc. to Host Fourth Quarter 2008 Earnings Conference Call at 8:30 a.m. EDT Wednesday March 18, 2009
9. China Yingxia International, Inc.s chairwoman and CEO is in talks with investors in China
10. China Healthcare Acquisition Corp. Announces Stockholder Approval of Charter Amendment to Permit Early Distribution of Its Trust Fund and to Permit Its Continued Existence Without Blank Check Company Provisions and Sets Payment Date
11. Chindex International, Inc. to Participate in the Piper Jaffray & ChinaVenture Investment Conference 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... 2017 , ... “Who Would Have Dreamed: A Novel of Miracles”: a beautiful and poignant ... understand its purpose in her life. “Who Would Have Dreamed: A Novel of Miracles” is ... love of writing. , Sharon shares that she started her spiritual journey later ...
(Date:1/24/2017)... ... ... “Mysteries Revealed On Speaking In Tongues”: an engaging and dynamic study on what ... On Speaking In Tongues” is the creation of published author, Tina Jackson, the editor, ... , “We need to partner with Jesus and be the voice piece to ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... research networking-technology company founded by patient survivors, today announced formation of its ... networking technologies and patient-inspired initiatives. , Like HCP founders, the global ...
(Date:1/24/2017)... ... January 23, 2017 , ... CLICKco LLC, a company known ... its CLICK® Coffee Protein Drink is now available for purchase on RevNutrition.com, a ... popular among health-conscious consumers who love coffee but are looking to add more ...
(Date:1/24/2017)... IL (PRWEB) , ... January 23, 2017 , ... ... is partnering with Plug and Play, the world’s largest start-up platform headquartered in ... companies a year. , OSF Ventures recently signed a three-year agreement to ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , Jan. 23, 2017  Based on its ... & Sullivan recognizes Ansell, a global leader in ... Sullivan Company of the Year Award. Ansell,s comprehensive ... a wide global footprint have placed it in ... protection market. The Company,s established product line and ...
(Date:1/23/2017)... -- Direct-to-consumer digital marketing strategy ... 65% increase in consumable sales, quarter-over-quarter ... DRIO ), a leader in digital health and ... Blood Glucose Monitoring System, an all-in-one diabetes meter, today ... minimally invasive smart diabetes management solution. ...
(Date:1/23/2017)... , Jan 23, 2017 Research and Markets ... Analysis & Trends - Product - Forecast to 2025" report to ... Report Highlights: ... and future market trends to identify the investment opportunities ... Key market trends across the business segments, Regions and ...
Breaking Medicine Technology: